![]() Products were ranked from 1 to 10 (best to worst) for compliance in four major categories: The level of UVB and UVA protection separately, the balance between the two, and the stability of the active ingredients, including any tendency to break down in sunlight or react with other ingredients to become less effective. “While manufacturers may be moving away from oxybenzone, a significant portion of the market is still made up of products using the 12 ingredients which can’t be considered safe and effective without further testing,” said David Andrews, EWG’s senior scientist. In the best sunscreen for recreational and beach application, 229 products met EWG criteria in the babies and children category 51 products met criteria and 128 products were included in the best daily use category.Ī doctor takes a patient's weight at during an appointment. By this year, the chemical was used in only 6% of tested products, which included sunscreens and daily moisturizers and lip balms with sunscreen protection.įor the 2023 report, EWG tested and ranked over 1,700 sunscreen products for their safety and effectiveness, grouping the results by use. In 2019, oxybenzone was an ingredient in 60% of all sunscreen products tested by EWG, dropping to 30% in 2022. Use of the ultraviolet ray blocker oxybenzone, which has been linked to human health harms and destruction of coral reefs, continues to decline, the report found. The 2023 report has some good news too, for both people and the planet. This year’s report, titled EWG 17th Annual Guide to Safer Sunscreens, was released in late May. “We found only 25% of sunscreens on the market offer good broad-spectrum protection without troublesome chemical ingredients,” said Emily Spilman, Healthy Living Science program manager for the Environmental Working Group, a nonprofit consumer advocacy group that has investigated sunscreen products for 17 years. ![]() ![]() Johnson and Johnson recalls some Neutrogena and Aveeno sunscreens after it detects benzene in them (AP Photo/Mark Lennihan) Mark Lennihan/AP Johnson & Johnson beat Wall Street's second-quarter expectations and bumped up its 2020 forecast even though COVID-19 chopped medical device revenue nearly 40 percent. Neutrogena sunblock, from Johnson & Johnson, is displayed in a pharmacy, Thursday, July 16, 2020, in New York.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |